(Q41550028)

3 October 2017

1 reference

title

Vancomycin-resistant enterococci: clinical, microbiologic, and epidemiologic features (English)

1 reference

3 October 2017

Noskin GA

1

1 reference

3 October 2017

publication date

1 July 1997

1 reference

3 October 2017

published in

Translational Research

1 reference

3 October 2017

volume

130

1 reference

3 October 2017

issue

1

1 reference

3 October 2017

page(s)

14-20

1 reference

Emergence of Enterococcus as a Significant Pathogen

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

The life and times of the Enterococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Vancomycin-Resistant Enterococcus faecium in Hospitalized Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Emergence of vancomycin-resistant enterococci in New York City

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Resistance of Enterococcus faecium to vancomycin and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Bacteremia due to vancomycin-resistant Enterococcus faecium of Van B phenotype during prophylaxis with vancomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Enterococcal superinfection in patients treated with ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Recommendations for preventing the spread of vancomycin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2897%2990054-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-2143(97)90054-8

1 reference

3 October 2017

1 reference